Abstract:

Objective: To observe the efficacy,security,and compliance of new hybrid fusion technology in the treatment of adult degenerative scoliosis (ADS),and to provide the basis for its clinical application.Methods: A total of 50 cases of ADS patients were divided into observation group(n=25) and control group(n=25).The patients in observation group were treated with new hybrid fusion technology,and the patients in control group were treated with traditional open surgery. The operation time,blood loss during the operation,surgical adherence,incidence of complications,improvement rate of lumbar function and fusion rate of bone graft of the patients in two groups were compared.Results: The operation time of patients in observation group was shorter than that in control group (t=6.199,P=6.199); the blood loss during the operation was less than that in control group (t=6.242,P=6.242). The total clinical effective rates of the patients in two groups had no statistically significant difference (χ²=0.758,P=0.758).The incidence of complications of the patients in observation group was lower than that those in control group (χ²=4.667,P=4.667), but the compliance rate were higher than that in control group (χ²=5.357,P=5.357).After treated for 1 and 3 months, the improvement rates of lumbar function and fusion rates of bone graft of the patients in two groups had no statistically significant differences (χ²=1.471,P=0.225; χ²=0.725,P=0.395; χ²=1.587,P=0.208; χ²=0.739,P=0.390);after treated for 6 and 12 months,the above data of the patients in observation group were higher than those in control group (χ²=4.500,P=0.034; χ²=4.667,P=0.031; χ²=5.357,P=0.021; χ²=7.018,P=0.008).Conclusion: New hybrid fusion technology used in ADS treatment has high security,good adherence,shorter operation time,less blood loss and other advantages, and it is suitable for clinical promotion.

Key words: new hybrid fusion technology, adult degenerative scoliosis, traditional open surgery, security, effect